Summary
The postsynaptic alpha-adrenoceptors of rabbit ear artery, dog splenic artery and dog splenic vein were characterized in vitro by the use of the selective antagonists prazosin (alpha1) and rauwolscine (alpha2). In isolated segments of rabbit aar artery, prazosin was a potent antagonist of norepinephrine-induced contraction, with a receptor dissociation constant (KB) of 6.4 nM. In contrast, rauwol-scine was effective only at very high concentrations (KB=4,000 nM), suggesting that the alpha-receptor of the ear artery has conventional alpha1-characteristics. The opposite order of potency was observed in a presynaptic alpha-receptor model, the isolated guinea pig atrium, where rauwolscine was potent (KB=4.5 nM) and prazosin essentially inactive.
Rauwolscine had an intermediate potency in the dog splenic vasculature, with a KB of 125 nM in splenic arterial segments and 5–15 nM in segments or helical strips of splenic vein. In contrast to the results with rauwolscine, prazosin was essentially equipotent in dog and rabbit tissues as an antagonist of norepinephrine-induced contraction (KB=3–9 nM). Schild analysis showed competitive antagonism for both rauwolscine and prazosin in all tissues. These results are consistent with the presence of a homogenous population of alpha-receptors in dog vasculature having characteristics of both the alpha1 and alpha2 receptor subtypes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48–58
Berthelsen S, Pettinger WA (1977) A funtional basis for classification of alpha-adrenergic receptors. Life Sci 21:595–606
Constantine JW, Gunnel D, Weeks RA (1980) Alpha1 and alpha2-vascular adrenoceptors in the dog. Eur J Pharmacol 66:281–286
Curro FA, Greenberg S (1983) Characteristics of postsynaptic alpha1 and alpha2 adrenergic receptors in canine vascular smooth muscle. Can J Physiol Pharmacol 61:893–904
DeMarinis RM, Hieble JP (1983) 1,2,3,4-Tetrahydro-8-methoxy-5-(methylthio)-2-naphtalenamine: A potent and selective agonist at alpha1-adrenoceptors. J Med Chem 26:1215–1218
DeMey J, Vanhoutte PM (1981) Uneven distribution of postjunctional alpha1 and alpha2-like adrenoceptors in canine arterial and venous smooth muscle. Circ Res 48:875–884
Docherty JR, McGrath JC (1980) A comparison of pre- and postjunctional potencies of several alpha-adrenoceptor agonists in the cardiovascular system and anococcygeus muscle of the rat. Naunyn-Schmiedeberg's Arch Pharmacol 312:107–116
Docherty JR, Starke K (1982) An examination of the pre- and postsynaptic alpha-adrenoceptors involved in neuroeffector transmission in rabbit aorta and portal vein. Br J Pharmacol 76:327–335
Doxey JC, Roach AG (1980) Presynaptic alpha-adrenoceptors: in vitro methods and preparations utilised in the evaluation of agonists and antagonists. J Auton Pharmacol 1:73–99
Drew GM, Whiting SB (1979) Evidence for two distinct types of postsynaptic alpha-adrenoceptors in vascular smooth muscle in vivo. Br J Pharmacol 67:207–215
Furchgott RF (1972) The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Eichler O, Farah A, Herken H, Welch AD (eds) Handbook of experimental pharmacology — New series. Springer, Berlin Heidelberg New York, pp 283–335
Grant JA, Scrutton MC (1979) Novel alpha2-adrenoceptors primarily responsible for inducing human platelet aggregation. Nature 277:659–661
Hieble JP, Pendleton RG (1979) Effects of ring substitution on the pre- and postjunctional alpha-adrenergic activity of aryliminoimidazolidines. Naunyn-Schmiedeberg's Arch Pharmacol 309:217–224
Horn PT, Kohli JD, Listinsky JJ, Goldberg LI (1982) Regional variation in the alpha-adrenergic receptors in the canine resistance vessels. Naunyn-Schmiedeberg's Arch Pharmacol 318:166–172
Kobinger W (1978) Central alpha-adrenergic systems as targets for hypotensive drugs. Rev Physiol Biochem Pharmacol 81:39–100
Kohli JD, Robertson MJ (1983) Alpha-adrenergic receptors of the rat aorta. Fed Proc 42:619
Lafontan M, Berlan M (1980) Evidence for the alpha2-nature of the alpha-adrenergic receptor inhibiting lipolysis in human fat cells. Eur J Pharmacol 66:87–93
Langer SZ (1974) Presynaptic regulation of catecholamine release. Biochem Pharmacol 23:1793–1800
Lasch P, Jakobs KH (1979) Agonistic and antagonistic effects of various alpha-adrenergic agonists in human platelets. Naunyn-Schmiedeberg's Arch Pharmacol 306:119–125
Macia RA, Matthews WD (1983) Assessment of alpha-receptor subtypes in isolated rat aortic segments. Fed Proc 42:649
McGrath JC (1982) Evidence for more than one type of postjunctional alpha-adrenoceptor. Biochem Pharmacol 31:467–484
Nakadate T, Nakaki T, Muraki T, Kato R (1980) Regulation of plasma insulin level by alpha2-adrenergic receptors. Eur J Pharmacol 65:421–424
Ruffolo RR, Waddell JE, Yaden EL (1982) Heterogeneity of postsynaptic alpha-adrenergic receptors in mammalian aortas. J Pharmacol Exp Ther 221:309–314
Schumann H-J, Lues I (1983) Postjunctional alpha-adrenoceptors in the isolated saphenous vein of the rabbit. Naunyn-Schmiedeberg's Arch Pharmacol 323:328–334
Shepperson NB, Langer SZ (1981) The effects of the 2-aminotetrahydronaphtalene derivation M7, a selective alpha2-adrenoceptor agonist in vitro. Naunyn-Schmiedeberg's Arch Pharmacol 318:10–13
Shoji T, Tsuru H, Shigei T (1983) A regional difference in the distribution of postsynaptic alpha-adrenoceptor subtypes in canine veins. Naunyn-Schmiedeberg's Arch Pharmacol 324:246–255
Skarby TVC, Anderson K-E, Edvinsson L (1983) Pharmacological characterization of postjunctional alpha-adrenoceptors in isolated feline cerebral and peripheral arteries. Acta Physiol Scand 117:63–73
Sullivan AT, Drew GM (1980) Pharmacological characterisation of pre- and postsynaptic alpha-adrenoceptors in dog saphenous vein. Naunyn-Schmiedeberg's Arch Pharmacol 314:249–258
Timmermans PBMWM, van Zwieten PA (1981) The post-synaptic alpha2-adrenoceptor. J Auton Pharmacol 1:171–183
Timmermans PBMWM, Kwa HY, van Zwieten PA (1979) Possible subdivision of postsynaptic alpha-adrenoceptors mediating pressor responses in the pithed rat. Naunyn-Schmiedeberg's Arch Pharmacol 310:189–193
Timmermans PBMWM, Schoop AMC, Kwa HY, van Zwieten PA (1981) Characterization of alpha-adrenoceptors participating in the central hypotensive and sedative effects of clonidine using yohimbine, rauwolscine and corynanthine. Eur J Pharmacol 70:7–15
Timmermans PBMWM, Wilffert B, Kalkman HO, Thoolen MJMC, van Meel JCA, de Jonge A, van Zwieten PA (1982) Selective inhibition of alpha2-adrenoceptor-mediated vasoconstriction in vivo by captopril and MK-421. Br J Pharmacol 75:135P
van Meel JCA, Wilffert B, Kalkman HO, Thoolen NJMC, de Jonge A, Timmermans PBMWM, van Zwieten PA (1982) Alpha2-adrenergic pressor responses and corticosteroids in the pithed rat. Br J Pharmacol 75:137P
van Zwieten PA (1980) Characterization of the central alpha-adrenoceptors involved in the hypotensive action of clonidine by yohimbine corynanthine and rauwolscine. Naunyn-Schmiedeberg's Arch Pharmacol 311: (suppl) R59
Wikberg JES (1979) The pharmacological classification of adrenergic alpha1 and alpha2 receptors and their mechanisms of action. Acta Physiol Scand Suppl 468:1–99
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hieble, J.P., Woodward, D.F. Different characteristics of postjunctional alpha-adrenoceptors on arterial and venous smooth muscle. Naunyn-Schmiedeberg's Arch. Pharmacol. 328, 44–50 (1984). https://doi.org/10.1007/BF00496105
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00496105